Corinne Marie Folberth

Title: Corinne Marie Folberth: Innovator in Aryl Hydrocarbon Receptor Inhibitors

Introduction

Corinne Marie Folberth is a notable inventor based in Durham, NC (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of aryl hydrocarbon receptor (AHR) inhibitors. With a total of two patents to her name, her work is paving the way for advancements in medical treatments.

Latest Patents

Corinne's latest patents include innovative formulations of (R)-N-(2-(5-fluoropyridin-3-yl)-8-isopropylpyrazolo[1,5-a][1,3,5]triazin-4-yl)-2,3,4,9-tetrahydro-1H-carbazol-3-amine. These compounds act as inhibitors of AHR and are useful for treating various conditions where the AHR is implicated. Her patents also cover solid forms of (R)-N-(2-(5-fluoropyridin-3-yl)-8-isopropylpyrazolo[1,5-a][1,3,5]triazin-4-yl)-2,3,4,9-tetrahydro-1H-carbazol-3-amine maleate, further expanding the potential applications of her research.

Career Highlights

Corinne is currently employed at Ikena Oncology, Inc., where she continues to innovate in the field of oncology. Her work focuses on developing new therapeutic options that can significantly impact patient care and treatment outcomes.

Collaborations

Throughout her career, Corinne has collaborated with esteemed colleagues such as Alfredo C. Castro and James Martin Nolan, III. These partnerships have enhanced her research and contributed to the successful development of her patented inventions.

Conclusion

Corinne Marie Folberth is a pioneering inventor whose work in AHR inhibitors is making strides in the pharmaceutical industry. Her contributions are vital for the advancement of medical treatments, showcasing her dedication to innovation and research.